tiprankstipranks
Ligand Pharma (LGND)
NASDAQ:LGND
Holding LGND?
Track your performance easily

Ligand Pharma (LGND) Financial Statements

797 Followers

Ligand Pharma Financial Overview

Ligand Pharma's market cap is currently ―. The company's EPS TTM is $2.513; its P/E ratio is 44.48; Ligand Pharma is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $1.18. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 51.81M$ 41.53M$ 30.98M$ 28.10M$ 32.87M
Gross Profit$ 49.36M$ 38.63M$ 28.10M$ 26.46M$ 29.38M
EBIT$ -6.34M$ -65.39M$ 113.59M-$ -12.14M
EBITDA$ 2.79M$ -56.28M$ 122.35M-$ -3.60M
Net Income Common Stockholders$ -7.17M$ -50.64M$ 86.14M$ 18.19M$ -10.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 219.64M$ 226.93M$ 310.59M$ 170.31M$ 190.50M
Total Assets$ 954.87M$ 866.40M$ 913.87M$ 787.22M$ 769.23M
Total Debt$ 7.36M$ 7.58M$ 6.19M$ 6.17M$ 6.33M
Net Debt$ -212.29M$ -219.35M$ -304.40M$ -164.14M$ -184.17M
Total Liabilities$ 113.69M$ 91.21M$ 107.35M$ 86.30M$ 101.33M
Stockholders Equity$ 841.18M$ 775.20M$ 806.52M$ 700.91M$ 667.90M
Cash Flow-
Free Cash Flow$ 35.93M$ 12.91M$ 18.63M-$ 7.16M
Operating Cash Flow$ 36.53M$ 13.31M$ 18.73M$ 8.06M$ 7.65M
Investing Cash Flow$ -46.51M$ -54.76M$ -3.77M$ -10.28M$ -19.50M
Financing Cash Flow$ 55.08M$ 9.49M$ 12.18M$ 5.32M$ 3.27M
Currency in USD

Ligand Pharma Earnings and Revenue History

Ligand Pharma Debt to Assets

Ligand Pharma Cash Flow

Ligand Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis